Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 06-2018 | 06-2017 | 06-2016 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 147 | 588 | 727 | 1,081 | 2,389 |
| Other Operating Activity | -4,490 | -4,946 | -5,864 | -6,710 | -10,496 |
| Operating Cash Flow | $-4,344 | $-4,358 | $-5,137 | $-5,630 | $-8,107 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | -2 | -137 | -216 | -113 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 1,757 |
| Other Investing Activity | -339 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-375 | $-2 | $-137 | $-216 | $1,644 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,799 |
| Common Stock Issued | 2,544 | N/A | 6,068 | N/A | 19,482 |
| Other Financing Activity | -309 | -8 | -708 | -1 | -2,152 |
| Financing Cash Flow | $2,236 | $-8 | $5,360 | $-1 | $19,129 |
| Exchange Rate Effect | 83 | 103 | -231 | 629 | 309 |
| Beginning Cash Position | 3,924 | 8,519 | 8,428 | 13,364 | 2,368 |
| End Cash Position | 1,525 | 4,254 | 8,284 | 8,146 | 15,343 |
| Net Cash Flow | $-2,400 | $-4,265 | $144 | $-5,218 | $12,974 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,344 | -4,358 | -5,137 | -5,630 | -8,107 |
| Capital Expenditure | -36 | -2 | -177 | -221 | -161 |
| Free Cash Flow | -4,380 | -4,360 | -5,314 | -5,851 | -8,268 |